Drug Safety and Pharmacovigilance Across the Product Lifecycle

Back to Agenda

Session 25: Benefit-Risk Management

Session Chair(s)

Jill W. Buckley, PharmD

Adjunct Assistant Professor

Rutgers, the State University of New Jersey, United States

The session will provide an introduction to benefit-risk assessment, with a focus on formal post-marketing risk management, primarily in the US and EU context. This session will encompass post-marketing risk assessment, Risk Management Plans (RMPs), and Risk Evaluation and Mitigation Strategies (REMS).

Have an account?

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Session 25: Benefit-Risk Management

Session Chair(s)

Jill W. Buckley, PharmD

Be informed and stay engaged.